A team of researchers has developed cancer-targeting peptides that could be used as “guided missiles” to treat various cancers and cancer stem cells without harming normal cells.
The research team last year won the National Innovation Award for its Fn cancer-targeting peptide technology, Chang Gung University Institute of Stem Cell and Translational Cancer Research director John Yu (游正博) told a news conference at the Ministry of Science and Technology in Taipei yesterday.
The team used computer-aided methods and novel scoring algorithms to design cancer-targeting peptides, which can guide various types of therapeutics to cancer cells, said Yu, an expert on stem cells and regenerative medicine.
Some cancer drugs are inefficient and cause painful side effects, because they cannot precisely target cancer cells, he said.
While other patented cancer-targeting peptides can only target a single cancer type, the team’s peptides can identify at least 11, including ovarian, gastric, lung, liver, breast, colorectal and pancreatic cancers, as demonstrated by laboratory and animal tests, Yu said.
The team’s peptides do not bind to healthy breast, peripheral blood, vascular endothelial cells or dermal fibroblasts, he said.
Instead of developing a drug for a specific cancer type — which can be a fairly time-consuming process — the team’s technology would help facilitate treatment for a variety of cancers, Yu said.
While there might be a long way to go before the technology could be used in clinical treatment, the team hopes that clinical experiments would start soon with advanced ovarian and gastric cancers, he said.
With the help of the ministry, the university and the government-funded Development Center for Biotechnology, the team last year established a start-up, UCT Bioscience, Yu said, adding that as he is focused on academic research, he did not take up a post at the firm.
Yu was last year a member of a delegation led by Minister of Science and Technology Chen Liang-gee (陳良基) to a conference in Washington between the ministry and the US National Institutes of Health.
Following the conference, Yu said that he is now working on new cancer therapeutics using the proprietary platform and the US agency’s technology.
US climber Alex Honnold is to attempt to scale Taipei 101 without a rope and harness in a live Netflix special on Jan. 24, the streaming platform announced on Wednesday. Accounting for the time difference, the two-hour broadcast of Honnold’s climb, called Skyscraper Live, is to air on Jan. 23 in the US, Netflix said in a statement. Honnold, 40, was the first person ever to free solo climb the 900m El Capitan rock formation in Yosemite National Park — a feat that was recorded and later made into the 2018 documentary film Free Solo. Netflix previewed Skyscraper Live in October, after videos
Starting on Jan. 1, YouBike riders must have insurance to use the service, and a six-month trial of NT$5 coupons under certain conditions would be implemented to balance bike shortages, a joint statement from transportation departments across Taipei, New Taipei City and Taoyuan announced yesterday. The rental bike system operator said that coupons would be offered to riders to rent bikes from full stations, for riders who take out an electric-assisted bike from a full station, and for riders who return a bike to an empty station. All riders with YouBike accounts are automatically eligible for the program, and each membership account
A classified Pentagon-produced, multiyear assessment — the Overmatch brief — highlighted unreported Chinese capabilities to destroy US military assets and identified US supply chain choke points, painting a disturbing picture of waning US military might, a New York Times editorial published on Monday said. US Secretary of Defense Pete Hegseth’s comments in November last year that “we lose every time” in Pentagon-conducted war games pitting the US against China further highlighted the uncertainty about the US’ capability to intervene in the event of a Chinese invasion of Taiwan. “It shows the Pentagon’s overreliance on expensive, vulnerable weapons as adversaries field cheap, technologically
NUMBERs IMBALANCE: More than 4 million Taiwanese have visited China this year, while only about half a million Chinese have visited here Beijing has yet to respond to Taiwan’s requests for negotiation over matters related to the recovery of cross-strait tourism, the Tourism Administration said yesterday. Taiwan’s tourism authority issued the statement after Chinese-language daily the China Times reported yesterday that the government’s policy of banning group tours to China does not stop Taiwanese from visiting the country. As of October, more than 4.2 million had traveled to China this year, exceeding last year. Beijing estimated the number of Taiwanese tourists in China could reach 4.5 million this year. By contrast, only 500,000 Chinese tourists are expected in Taiwan, the report said. The report
RSS